Literature DB >> 28480316

Expression and Purification of Mini G Proteins from Escherichia coli.

Byron Carpenter1, Christopher G Tate1.   

Abstract

Heterotrimeric G proteins modulate intracellular signalling by transducing information from cell surface G protein-coupled receptors (GPCRs) to cytoplasmic effector proteins. Structural and functional characterisation of GPCR-G protein complexes is important to fully decipher the mechanism of signal transduction. However, native G proteins are unstable and conformationally dynamic when coupled to a receptor. We therefore developed an engineered minimal G protein, mini-Gs, which formed a stable complex with GPCRs, and facilitated the crystallisation and structure determination of the human adenosine A2A receptor (A2AR) in its active conformation. Mini G proteins are potentially useful tools in a variety of applications, including characterising GPCR pharmacology, binding affinity and kinetic experiments, agonist drug discovery, and structure determination of GPCR-G protein complexes. Here, we describe a detailed protocol for the expression and purification of mini-Gs.

Entities:  

Keywords:  Complex; Engineered G protein; G protein-coupled receptor; GPCR; Mini G protein; Mini-Gs

Year:  2017        PMID: 28480316      PMCID: PMC5419499          DOI: 10.21769/BioProtoc.2235

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  4 in total

1.  Expression and purification of soluble His(6)-tagged TEV protease.

Authors:  Joseph E Tropea; Scott Cherry; David S Waugh
Journal:  Methods Mol Biol       Date:  2009

2.  Expression, Purification and Crystallisation of the Adenosine A2A Receptor Bound to an Engineered Mini G Protein.

Authors:  Byron Carpenter; Christopher G Tate
Journal:  Bio Protoc       Date:  2017-04-20

3.  Structure of the adenosine A(2A) receptor bound to an engineered G protein.

Authors:  Byron Carpenter; Rony Nehmé; Tony Warne; Andrew G W Leslie; Christopher G Tate
Journal:  Nature       Date:  2016-07-27       Impact factor: 49.962

4.  Engineering a minimal G protein to facilitate crystallisation of G protein-coupled receptors in their active conformation.

Authors:  Byron Carpenter; Christopher G Tate
Journal:  Protein Eng Des Sel       Date:  2016-09-26       Impact factor: 1.650

  4 in total
  7 in total

1.  Molecular basis for high-affinity agonist binding in GPCRs.

Authors:  Tony Warne; Patricia C Edwards; Andrew S Doré; Andrew G W Leslie; Christopher G Tate
Journal:  Science       Date:  2019-05-09       Impact factor: 47.728

2.  A Native PAGE Assay for the Biochemical Characterization of G Protein Coupling to GPCRs.

Authors:  Amanda M Roehrkasse; Jordan A Karim; Augen A Pioszak
Journal:  Bio Protoc       Date:  2021-12-20

3.  Expression, Purification and Crystallisation of the Adenosine A2A Receptor Bound to an Engineered Mini G Protein.

Authors:  Byron Carpenter; Christopher G Tate
Journal:  Bio Protoc       Date:  2017-04-20

Review 4.  Human Adenosine A2A Receptor: Molecular Mechanism of Ligand Binding and Activation.

Authors:  Byron Carpenter; Guillaume Lebon
Journal:  Front Pharmacol       Date:  2017-12-14       Impact factor: 5.810

5.  Cryo-EM structure of the adenosine A2A receptor coupled to an engineered heterotrimeric G protein.

Authors:  Javier García-Nafría; Yang Lee; Xiaochen Bai; Byron Carpenter; Christopher G Tate
Journal:  Elife       Date:  2018-05-04       Impact factor: 8.140

6.  Strategic Screening and Characterization of the Visual GPCR-mini-G Protein Signaling Complex for Successful Crystallization.

Authors:  Filip Pamula; Jonas Mühle; Alain Blanc; Rony Nehmé; Patricia C Edwards; Christopher G Tate; Ching-Ju Tsai
Journal:  J Vis Exp       Date:  2020-03-16       Impact factor: 1.355

7.  Crystal structure of rhodopsin in complex with a mini-Go sheds light on the principles of G protein selectivity.

Authors:  Ching-Ju Tsai; Filip Pamula; Rony Nehmé; Jonas Mühle; Tobias Weinert; Tilman Flock; Przemyslaw Nogly; Patricia C Edwards; Byron Carpenter; Thomas Gruhl; Pikyee Ma; Xavier Deupi; Jörg Standfuss; Christopher G Tate; Gebhard F X Schertler
Journal:  Sci Adv       Date:  2018-09-19       Impact factor: 14.136

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.